Concepedia
Statistics
Publications
6
Citations
577
H-Index
Active since
2002
Affiliations
Can-Fite BioPharma (Israel)(Current)
Tel Aviv University
Rabin Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases
Meir Medical Center
R. Patoka is an author at Can-Fite BioPharma (Israel) specializing in pharmacology, adenosine receptor signaling, and inflammation.
Publications per year
2002–2012
Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment
S. Bar‐Yehuda, Lea Rath‐Wolfson, Luis Del Valle et al. · Arthritis & Rheumatism · 2009 · 126 citations
Medicine, Pharmacology, Pharmacotherapy +17
The anti-inflammatory target A3 adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn’s disease
Avivit Ochaion, S. Bar‐Yehuda, Shira Cohen et al. · Cellular Immunology · 2009 · 118 citations
Medicine, Immunology, Pharmacology +13
CF102 for the Treatment of Hepatocellular Carcinoma: A Phase I/II, Open-Label, Dose-Escalation Study
Salomon M. Stemmer, Ofer Benjaminov, Gal Medalia et al. · The Oncologist · 2012 · 92 citations · Full text
Medicine, Oncology, Pharmacology +16
Analysis of endogenous peptides bound by soluble MHC class I molecules: a novel approach for identifying tumor-specific antigens
Eilon Barnea, Ilan Beer, R. Patoka et al. · European Journal of Immunology · 2002 · 91 citations · Full text
Life Sciences, Immunology, Oncology +17
CF102 an A<sub>3</sub> adenosine receptor agonist mediates anti‐tumor and anti‐inflammatory effects in the liver
Shira Cohen, Salomon M. Stemmer, G. Zozulya et al. · Journal of Cellular Physiology · 2010 · 80 citations · Full text
Life Sciences, Oncology, Pharmacology +15
1–5 of 6